Comparing immunoglobulin A vasculitis (Henoch–Schönlein purpura) in children and adults: a single-centre study from Turkey

Scandinavian Journal of Rheumatology

Volumn 47, Issue 6, 2018, Pages 481-486

  Batu, E D ^a   Sari A ^a   Erden, A ^a   Sonmez H E ^a   Armagan B ^a   Kalyoncu, U ^a   Karadağ, Ö ^a   Bilginer, Y ^a   Akdogan A ^a   Kiraz, S ^a   Ozen S ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; PREDNISOLONE; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNE COMPLEX DEPOSITION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PLATELET COUNT; PRIORITY JOURNAL; PROTEINURIA; PURPURA; RELAPSE; RENOVASCULAR HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; SKIN BIOPSY; TURKEY (REPUBLIC); UPPER RESPIRATORY TRACT INFECTION; AGE; MIDDLE AGED; PRESCHOOL CHILD; RECURRENT DISEASE; TURKEY (BIRD); YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PURPURA, SCHOENLEIN-HENOCH; RECURRENCE; RETROSPECTIVE STUDIES; TURKEY; YOUNG ADULT;

EID: 85048835726     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009742.2018.1448111     Document Type: Article

References (34)

1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1–11.
2. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR., Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002;360:1197–202.
3. Gedalia A. Henoch-Schonlein purpura. Curr Rheumatol Rep 2004;6:195–202.
4. Atkinson SR, Barker DJ. Seasonal distribution of Henoch-Schonlein purpura. Br J Prev Soc Med 1976;30:22–5.
5. Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura. J Korean Med Sci 2014;29:198–203.
6. Karadag O, Erden A, Batu ED, Bilgin E, Uyaroglu AO, Seyhoglu E, et al. Distribution of vasculitides in Eastern Mediterranean: results of a prospective cohort (FRI0342 abstract). Ann Rheum Dis 2017;(Suppl 2):616.
7. Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez-Gay MA. Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 2002;32:149–56.
8. Byun JW, Song HJ, Kim L, Shin JH, Choi GS. Predictive factors of relapse in adult with Henoch-Schonlein purpura. Am J Dermatopathol 2012;34:139–44.
9. Prais D, Amir J, Nussinovitch M. Recurrent Henoch-Schonlein purpura in children. J Clin Rheumatol 2007;13:25–8.
10. Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A. Predictive factors of renal involvement or relapsing disease in children with Henoch-Schonlein purpura. Rheumatol Int 2005;25:45–8.
11. Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schonlein purpura. Scand J Rheumatol 2006;35:56–60.
12. Calvo-Rio V, Hernandez JL, Ortiz-Sanjuan F, Loricera J, Palmou-Fontana N, Gonzalez-Vela MC, et al. Relapses in patients with Henoch-Schonlein purpura: analysis of 417 patients from a single center. Medicine (Baltimore) 2016;95:e4217.
13. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990;33:1114–21.
14. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010;69:798–806.
15. WHO. Haemoglobin concentrations for the diagnosis of anaemina and assessment of severity (http://apps.who.int/iris/bitstream/10665/85839/3/WHO_NMH_NHD_MNM_11.1_eng.pdf?ua=1). Accessed 3 March 2018.
16. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M, Gonzalez-Gay MA. Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997;40:859–64.
17. Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL. Clinical manifestations and outcomes of Henoch-Schonlein purpura: comparison between adults and children. Pediatr Neonatol 2009;50:162–8.
18. Lin SJ, Huang JL. Henoch-Schonlein purpura in Chinese children and adults. Asian Pac J Allergy Immunol 1998;16:21–5.
19. Liu Z, Wei YD, Hou Y, Xu Y, Li XJ, Du YJ. Differences in pathological characteristics and laboratory indicators in adult and pediatric patients with Henoch-Schonlein purpura nephritis. J Huazhong Univ Sci Technolog Med Sci 2016;36:659–66.
20. Ilan Y, Naparstek Y. Schonlein-Henoch syndrome in adults and children. Semin Arthritis Rheum 1991;21:103–9.
21. Uppal SS, Hussain MA, Al-Raqum HA, Nampoory MR, Al-Saeid K, Al-Assousi A, et al. Henoch-Schonlein’s purpura in adults versus children/adolescents: a comparative study. Clin Exp Rheumatol 2006;24(Suppl 41):S26–30.
22. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, et al. Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis 2006;47:993–1003.
23. Lopez-Mejias R, Carmona FD, Castaneda S, Genre F, Remuzgo-Martinez S, Sevilla-Perez B, et al. A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis. Sci Rep 2017;7:5088.
24. Lopez-Mejias R, Genre F, Perez BS, Castaneda S, Ortego-Centeno N, Llorca J, et al. HLA-DRB1 association with Henoch-Schonlein purpura. Arthritis Rheumatol 2015;67:823–7.
25. Lu S, Liu D, Xiao J, Yuan W, Wang X, Zhang X, et al. Comparison between adults and children with Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2015;30:791–6.
26. Biino G, Santimone I, Minelli C, Sorice R, Frongia B, Traglia M, et al. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects’ data. PloS One 2013;8:e54289.
27. Faull RJ, Aarons I, Woodroffe AJ, Clarkson AR. Adult Henoch-Schonlein nephritis. Aust N Z J Med 1987;17:396–401.
28. Saulsbury FT. Clinical update: henoch-Schonlein purpura. Lancet 2007;369:976–8.
29. Us Be B, Ozen S. Treatment of Henoch-Schönlein purpura: what evidence do we have? Int J Clin Rheumatol 2010;5:669–76.
30. Gonzalez-Gay MA, Blanco R, Castaneda S. Henoch-Schonlein purpura (IgA vasculitis): the paradox of the different incidence and clinical spectrum in children and adults. Clin Exp Rheumatol 2017;35:3–4.
31. Garcia-Porrua C, Gonzalez-Gay MA. Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch-Schonlein purpura in adults. Semin Arthritis Rheum 1999;28:404–12.
32. Alfredo CS, Nunes NA, Len CA, Barbosa CM, Terreri MT, Hilario MO. Henoch-Schonlein purpura: recurrence and chronicity. J Pediatr 2007;83:177–80.
33. Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodriguez-Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001;80:279–90.
34. Garcia-Porrua C, Gonzalez-Louzao C, Llorca J, Gonzalez-Gay MA. Predictive factors for renal sequelae in adults with Henoch-Schonlein purpura. J Rheumatol 2001;28:1019–24.